TScan Therapeutics’ $100M Series C Financing

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised TScan Therapeutics on the deal. TScan Therapeutics, a biotechnology company developing immunotherapy treatments for cancer, announced its…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here